» Articles » PMID: 35693963

Understanding Behavior in Phelan-McDermid Syndrome

Overview
Specialty Psychiatry
Date 2022 Jun 13
PMID 35693963
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Phelan-McDermid syndrome (PMS) or 22q13.3 deletion syndrome is a rare genetic disorder characterized by developmental delay, hypotonia and severely delayed speech. Behavioral difficulties are often reported in PMS, although knowledge of behavioral profiles and the interpretation of reported behavior remains limited. Understanding the meaning of behavior requires considering the context as well as other domains of functioning, for example the individual's level of cognitive, social and emotional development. Combining structured direct in-person neurodevelopmental assessments with contextual assessments to enable meaningful interpretations of reported behavior on functional dimensions across multiple units of analysis, as proposed by the RDoc framework, is essential.

Methods: In this article we present a structured multidisciplinary method of assessment through direct in-person neurodevelopmental assessments and assessment of contextual factors. Our study sample includes data of 33 children with an average age of 6.2 years (range 1.1 to 15.7) with PMS, obtained through individual in-person assessments in combination with parent informed questionnaires. We assessed developmental age using the Bayley-III, adaptive behavior was assessed with the Vineland screener, social-emotional development with the ESSEON-R and behavior by using the CBCL.

Results: Our results show a great deal of variability in phenotypic presentation with regard to behavior, symptom expression and symptom severity in individuals with PMS. The data on behavior is interpreted in the context of the individual's level of cognitive, adaptive development and the (genetic) context. Behavioral data showed high levels of withdrawn behavior and attention problems. More than half of the children showed borderline or clinical symptoms related to Autism Spectrum Disorder (ASD).

Conclusions: The interpretation of the meaning of certain behavior in PMS is often based on questionnaires and descriptions without taking the specific context of development into account. Combining questionnaires with direct in-person assessments measuring different domains of functioning should be considered a more accurate method to interpret the meaning of findings in order to understand behavior in rare genetic disorders associated with developmental delay such as PMS. Direct in-person assessment provides valuable and specific information relevant to understanding individual behavior and inform treatment as well as increase knowledge of the neurodevelopmental phenotype in individuals with PMS. More specific application of the proposed frameworks on behavior in PMS is desirable in making useful interpretations.

Citing Articles

Diagnosis and treatment of bipolar disorder in Phelan-McDermid syndrome: A case report and review of literature.

Sun Y, Xia Y, Zhi Q, Liu X World J Psychiatry. 2025; 15(2):101948.

PMID: 39974483 PMC: 11758057. DOI: 10.5498/wjp.v15.i2.101948.


Behavioral and Psychiatric Disorders in Syndromic Autism.

Genovese A, Butler M Brain Sci. 2024; 14(4).

PMID: 38671997 PMC: 11048128. DOI: 10.3390/brainsci14040343.


Early-onset catatonia associated with mutations: looking at the autism spectrum through the prism of psychomotor phenomena.

Dhossche D, de Billy C, Laurent-Levinson C, Le Normand M, Recasens C, Robel L Front Psychiatry. 2023; 14:1186555.

PMID: 37810596 PMC: 10557257. DOI: 10.3389/fpsyt.2023.1186555.


Neurodegeneration or dysfunction in Phelan-McDermid syndrome? A multimodal approach with CSF and computational MRI.

Jesse S, Muller H, Huppertz H, Andres S, Ludolph A, Schon M Orphanet J Rare Dis. 2023; 18(1):274.

PMID: 37670319 PMC: 10481508. DOI: 10.1186/s13023-023-02863-7.

References
1.
Oberman L, Boccuto L, Cascio L, Sarasua S, Kaufmann W . Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations. Orphanet J Rare Dis. 2015; 10:105. PMC: 4549933. DOI: 10.1186/s13023-015-0323-9. View

2.
van Duijn G, Dijkxhoorn Y, Noens I, Scholte E, van Berckelaer-Onnes I . Vineland Screener 0-12 years research version (NL). Constructing a screening instrument to assess adaptive behaviour. Int J Methods Psychiatr Res. 2009; 18(2):110-7. PMC: 6878323. DOI: 10.1002/mpr.282. View

3.
Phelan K, McDermid H . The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome). Mol Syndromol. 2012; 2(3-5):186-201. PMC: 3366702. DOI: 10.1159/000334260. View

4.
Verhoeven W, Egger J, de Leeuw N . A longitudinal perspective on the pharmacotherapy of 24 adult patients with Phelan McDermid syndrome. Eur J Med Genet. 2019; 63(3):103751. DOI: 10.1016/j.ejmg.2019.103751. View

5.
Sarasua S, Dwivedi A, Boccuto L, Chen C, Sharp J, Rollins J . 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome. Genet Med. 2013; 16(4):318-28. DOI: 10.1038/gim.2013.144. View